Lifescan's Harmony INR
This article was originally published in The Gray Sheet
Executive Summary
U.S. distribution of the device for monitoring and management of oral coagulation therapy using Coumadin (warfarin) will be handled by the Johnson & Johnson subsidiary, not St. Jude Medical (1"The Gray Sheet" Sept. 10, 2001, p. 13). St. Jude has an exclusive marketing agreement to promote Harmony to mechanical heart valve patients
You may also be interested in...
Lifescan Looks To InDuo Launch To Help Sustain 2001 Diabetes Care Growth
Johnson & Johnson's Lifescan unit is counting on this month's U.S. launch of the One Touch InDuo combination glucose monitoring and insulin dosing system to help sustain robust base operating growth following an 11% gain in the first half of 2001.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.